Policy | February 02, 2023
Budget 2023-24: Industry welcomes focus on medical research and pharma innovation
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
OriCiro's synthetic biology and enzyme technologies will support Moderna's expanding portfolio of therapeutics and vaccines
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
MindRank expects to initiate a Phase I safety study in the first quarter of 2023.
The product is backed by required scientific proof and comparative bioequivalence studies
AUR101, with a good ADME/PK profile and high bioavailability, has demonstrated inhibition of IL-17A in whole blood from psoriasis patients
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
This is the first injectable product approval from our General Sterile Facility (F-3) which was inspected in August, 2022.
Oncodesign Services (ODS ), with 600 clients in 33 countries and 227 employees worldwide, provides services from target identification to hit-to-lead and lead optimization through to IND filing.
Subscribe To Our Newsletter & Stay Updated
